To our knowledge, this is the first study examining the connection between the CD34+ cell count and the markers of PAD severity and risk factors for atherosclerosis (diabetes mellitus, smoking, dyslipidaemia) in patients with advanced PAD. Here, CD34 is linked to inherited lipid metabolism disorder.